Works matching IS 08909091 AND DT 2014 AND VI 28 AND IP 2
Results: 13
ACR Appropriateness Criteria® Local-Regional Recurrence (LRR) and Salvage Surgery--Breast Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 157
- By:
- Publication type:
- Article
Baseline PSA Testing for Men in Their 40s: Testing in Average-Risk Men Aged 40 to 50 Years Should Not Be Routinely Performed.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 155
- By:
- Publication type:
- Article
Baseline PSA Testing for Men in Their 40s: Currently Available Evidence Strongly Supports Baseline PSA Measurements in This Age Group.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 154
- By:
- Publication type:
- Article
ASCO Gl: 2014 Symposium Highlights.
- Published in:
- 2014
- Publication type:
- Interview
Improving the Early Detection of Prostate Cancer: A Balancing Act.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
One Institution's Experience With Implementation of EPIC/Beacon: Lessons Learned.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 105
- By:
- Publication type:
- Article
Precision Medicine Approaches to the Diagnosis and Management of Prostate Cancer.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
New Biomarkers in Prostate Cancer.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 135
- By:
- Publication type:
- Article
Improved Metastatic Uterine Papillary Serous Cancer Outcome With Treatment of Mast Cell Activation Syndrome.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Colorectal Cancer and Molecular Targeted Agents: Progress--With Caveats.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
The Utility of Molecular Testing in Colorectal Cancer: The Promise Needs Progress.
- Published in:
- 2014
- By:
- Publication type:
- Opinion
Colorectal Cancer: How Emerging Molecular Understanding Affects Treatment Decisions.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 110
- By:
- Publication type:
- Article
Personalized Medicine and Anti-EGFR Antibody Therapy in the Treatment of Metastatic Colorectal Cancer: KRAS and Beyond.
- Published in:
- Oncology (08909091), 2014, v. 28, n. 2, p. 96
- By:
- Publication type:
- Article